For pharma, an industry in which gross margins are among the highest in the S&P 500, labor was never really the reason for moving offshore to places like Ireland—it was always about playing the ...

The pharma industry’s reputation has continued to slide — and it’s mostly due to the persistent issue of high drug costs, according to a report released by research firm PatientView this week.

But these same areas are now overcrowded, and price wars are common. Companies like Mankind, Sun Pharma, and Intas are looking at combinations of brand innovation, portfolio reshuffling ...

RALEIGH, N.C., April 14, 2025 /PRNewswire/ -- Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of ...

Minoxidil is a topical solution that helps stimulate hair growth. However, is it possible that it could do the opposite? After one woman stopped using minoxidil, it caused another problem that she ...

Indian pharma stocks were in focus on Thursday (April 3, 2025) early trading hours after the generic drugmakers got an exemption from U.S. tariff levy. Also read: Front-end manufacturing in U.S ...

Zero. That revelation was part of a Senate Finance Committee investigation done by Democratic staff, released in March, that examined how U.S. pharmaceutical giants exploit a loophole created by ...

Minoxidil Foam vs Liquid: Which is the Best for Hair Growth? This article was reviewed by Knox Beasley, MD. Topical minoxidil (the generic version of Rogaine) is an effective, research-backed, FDA ...

In December, a Food and Drug Administration investigation prompted Intas Pharmaceuticals to suspend the production of cisplatin because of concerns over the quality of the drug. The company ...

Gujarat-based drugmaker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment Authority (ADIA) as its investors, ...

A Triangle pharmaceutical firm is expanding its portfolio as its parent company completes a $500 million deal. © 2025 American City Business Journals. All rights ...

Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, plans to assume full ...